Kaituo Pharmaceutical-B (09939) fell by more than 10%. As of press release, it was down 9.7% to HK$1.49, with a turnover of HK$6.410,000.
The Zhitong Finance App learned that Kaituo Pharmaceutical-B (09939) fell by more than 10%. As of press release, it was down 9.7% to HK$1.49, with a turnover of HK$6.410,000.
According to the news, Hang Seng Index Limited recently announced the results of a series of quarterly reviews of the Hang Seng Index up to December 31, 2023, showing that 32 individual stocks were excluded from the Hong Kong Stock Connect Index, including Pioneer Pharmaceuticals. According to reports, Kaituo Pharmaceutical continued to lose money during the three years of its listing, and the cumulative loss amount has exceeded 2 billion yuan. As of the end of June last year, the company's cash and cash equivalents were only 691 million yuan, and the cash flow situation was not optimistic.